Inhaled steroids are drugs which are administered in case of asthma by kids and grown-ups. Persons that have mild, moderate and severe asthma use these medicines each day. These medications prevent inflammation of the airways. Health care providers supervise patients with this disease, adjusting dosage schedule every 6 weeks.
Unfortunately, inhaled steroids, like other medications, may lead to adverse reactions. Regular usage of these preparations is connected with several risks. Is there any way for individuals with asthma to avoid these problems?
A recent study has demonstrated that physicians should not recommend applying these products daily to persons with mild-to-moderate asthma. This research turned out to be very valuable. It is likely to alter instructions related to treatment of asthma.
The study was conducted by scientists of the Texas Medical Brach in Galveston. The doctor William Calhoun and his colleagues enrolled 340 persons with asthma in the study. Some persons received inhaled corticosteroids daily; others took these products, when symptoms of asthma attacks appeared. Bronchial reactivity and functions of lungs were measured by the scientists during nine months. The results of the research demonstrated that there was not any essential difference between these two groups.
According to the scientists, if inhaled steroids are applied, when symptoms appear, exacerbation can be prevented. Furthermore, these medicines have prolonged action. It means that positive effects are felt even certain days after administration. The scientists suggest that these medications may be applied by individuals with mild-to-moderate asthma only when symptoms appear.
Why is this research valuable? According to certain sources, 25 million Americans experience asthma. Of course, they should be treated. This piece of news must be valuable for them. Furthermore, if inhaled steroids are taken prolonged period of time, they may cause grave negative effects, such as hormonal imbalance, cataract, etc. Thus, if persons that suffer from mild-to-moderate asthma don’t use these drugs every day, they are more unlikely to get these unwanted reactions.
Undoubtedly, it is early to alter recommendations linked with treatment of asthma. But this study may serve as a basis for further researches that may lead to certain changes.
Комментариев нет:
Отправить комментарий